Jennifer Lee's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 55,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 55,000 | 55,000 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 36,650 | 36,650 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,500 | 7,893 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,500 | 16,500 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 14 Feb 2025 | 2,035 | 5,858 (0%) | 0% | 57.2 | 116,443 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 56.39 per share. | 12 Feb 2025 | 1,205 | 3,598 (0%) | 0% | 56.4 | 67,950 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 58.00 per share. | 12 Feb 2025 | 1,205 | 2,393 (0%) | 0% | 58 | 69,890 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 56.39 per share. | 12 Feb 2025 | 600 | 4,813 (0%) | 0% | 56.4 | 33,834 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 56.40 per share. | 12 Feb 2025 | 10 | 4,803 (0%) | 0% | 56.4 | 564 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 Feb 2025 | 4,189 | 8,598 (0%) | 0% | 6.8 | 28,485 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 4,189 | 21,601 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 3,437 | 4,409 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 3,437 | 3,437 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 59.34 per share. | 09 Feb 2025 | 2,295 | 4,409 (0%) | 0% | 59.3 | 136,187 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,031 | 6,440 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,031 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 58.39 per share. | 09 Feb 2025 | 1,894 | 6,704 (0%) | 0% | 58.4 | 110,596 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 57.51 per share. | 09 Feb 2025 | 1,023 | 5,417 (0%) | 0% | 57.5 | 58,833 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 09 Feb 2025 | 4 | 5,413 (0%) | 0% | 57.5 | 230 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 60.08 per share. | 05 Feb 2025 | 1,733 | 2,305 (0%) | 0% | 60.1 | 104,121 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 61.02 per share. | 05 Feb 2025 | 1,133 | 1,172 (0%) | 0% | 61.0 | 69,130 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 61.95 per share. | 05 Feb 2025 | 200 | 972 (0%) | 0% | 62.0 | 12,390 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 4,513 | 9,024 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 4,513 | 5,485 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 59.43 per share. | 01 Feb 2025 | 1,447 | 4,038 (0%) | 0% | 59.4 | 85,995 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 65.68 per share. | 11 Nov 2024 | 38,051 | 29,782 (0%) | 0% | 65.7 | 2,499,049 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 28,717 | 71,283 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.29 per share. | 11 Nov 2024 | 28,717 | 56,191 (0%) | 0% | 24.3 | 697,536 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 11 Nov 2024 | 20,622 | 27,474 (0%) | 0% | 6.8 | 140,230 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 20,622 | 25,790 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 66.95 per share. | 11 Nov 2024 | 17,540 | 12,242 (0%) | 0% | 66.9 | 1,174,275 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 11,642 | 37,108 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.66 per share. | 11 Nov 2024 | 11,642 | 67,833 (0%) | 0% | 30.7 | 356,944 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 67.56 per share. | 11 Nov 2024 | 11,070 | 1,172 (0%) | 0% | 67.6 | 747,873 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Lee | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 68.43 per share. | 11 Nov 2024 | 200 | 972 (0%) | 0% | 68.4 | 13,686 | Common Stock |